148 related articles for article (PubMed ID: 25749520)
21. Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma.
Rizzo F; Rinaldi A; Marchese G; Coviello E; Sellitto A; Cordella A; Giurato G; Nassa G; Ravo M; Tarallo R; Milanesi L; Destro A; Torzilli G; Roncalli M; Di Tommaso L; Weisz A
Oncotarget; 2016 Aug; 7(34):54650-54661. PubMed ID: 27429044
[TBL] [Abstract][Full Text] [Related]
22. Proteomic Characterization of Annexin l (ANX1) and Heat Shock Protein 27 (HSP27) as Biomarkers for Invasive Hepatocellular Carcinoma Cells.
Wang RC; Huang CY; Pan TL; Chen WY; Ho CT; Liu TZ; Chang YJ
PLoS One; 2015; 10(10):e0139232. PubMed ID: 26431426
[TBL] [Abstract][Full Text] [Related]
23. The Diagnostic Role of SPINK1 in Differentiating Hepatocellular Carcinoma From Nonmalignant Lesions.
Holah NS; El-Azab DS; Aiad HAE; Sweed DMM
Appl Immunohistochem Mol Morphol; 2017; 25(10):703-711. PubMed ID: 27028242
[TBL] [Abstract][Full Text] [Related]
24. A novel panel of biomarkers in distinction of small well-differentiated HCC from dysplastic nodules and outcome values.
Jin GZ; Dong H; Yu WL; Li Y; Lu XY; Yu H; Xian ZH; Dong W; Liu YK; Cong WM; Wu MC
BMC Cancer; 2013 Mar; 13():161. PubMed ID: 23537217
[TBL] [Abstract][Full Text] [Related]
25. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T
Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081
[TBL] [Abstract][Full Text] [Related]
26. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
[TBL] [Abstract][Full Text] [Related]
27. Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma.
Shen Q; Eun JW; Lee K; Kim HS; Yang HD; Kim SY; Lee EK; Kim T; Kang K; Kim S; Min DH; Oh SN; Lee YJ; Moon H; Ro SW; Park WS; Lee JY; Nam SW
Hepatology; 2018 Apr; 67(4):1360-1377. PubMed ID: 29059470
[TBL] [Abstract][Full Text] [Related]
28. Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.
Xu X; Liu Z; Wang J; Xie H; Li J; Cao J; Zhou L; Zheng S
Oncotarget; 2016 Mar; 7(12):13730-41. PubMed ID: 26883192
[TBL] [Abstract][Full Text] [Related]
29. Vascular immunohistochemical markers: contributions to hepatocellular nodule diagnosis in explanted livers.
Nascimento C; Caroli-Bottino A; Paschoal J; Pannain VL
Transplant Proc; 2009 Dec; 41(10):4211-3. PubMed ID: 20005371
[TBL] [Abstract][Full Text] [Related]
30. Low-Grade Dysplastic Nodules Revealed as the Tipping Point during Multistep Hepatocarcinogenesis by Dynamic Network Biomarkers.
Lu L; Jiang Z; Dai Y; Chen L
Genes (Basel); 2017 Oct; 8(10):. PubMed ID: 29027943
[TBL] [Abstract][Full Text] [Related]
31. A Large Set of miRNAs Is Dysregulated from the Earliest Steps of Human Hepatocellular Carcinoma Development.
Sulas P; Di Tommaso L; Novello C; Rizzo F; Rinaldi A; Weisz A; Columbano A; Roncalli M
Am J Pathol; 2018 Mar; 188(3):785-794. PubMed ID: 29248455
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value.
Wachter DL; Kristiansen G; Soll C; Hellerbrand C; Breuhahn K; Fritzsche F; Agaimy A; Hartmann A; Riener MO
Histopathology; 2012 Jan; 60(2):278-86. PubMed ID: 22211286
[TBL] [Abstract][Full Text] [Related]
33. Differential diagnostic value of GPC3-CD34 combined staining in small liver nodules with diameter less than 3 cm.
Wang F; Jing X; Wang T; Li G; Li T; Zhang Q; Huang Y; Li J; Wang Y; Gao Y; Han T; Du Z
Am J Clin Pathol; 2012 Jun; 137(6):937-45. PubMed ID: 22586053
[TBL] [Abstract][Full Text] [Related]
34. Expression of CD34 in cirrhotic liver--reliance to dedifferentiation.
Gligorijević J; Djordjević B; Petrović A; Radirević A; Stojanović S
Vojnosanit Pregl; 2010 Jun; 67(6):459-62. PubMed ID: 20629423
[TBL] [Abstract][Full Text] [Related]
35. Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis.
Park JY; Park WS; Nam SW; Kim SY; Lee SH; Yoo NJ; Lee JY; Park CK
Liver Int; 2005 Feb; 25(1):70-6. PubMed ID: 15698401
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver.
Nakamura K; Zen Y; Sato Y; Kozaka K; Matsui O; Harada K; Nakanuma Y
Hum Pathol; 2007 Oct; 38(10):1532-46. PubMed ID: 17640715
[TBL] [Abstract][Full Text] [Related]
37. Update on precursor and early lesions of hepatocellular carcinomas.
Park YN
Arch Pathol Lab Med; 2011 Jun; 135(6):704-15. PubMed ID: 21631263
[TBL] [Abstract][Full Text] [Related]
38. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
39. Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis.
Oh BK; Jo Chae K; Park C; Kim K; Jung Lee W; Han KH; Nyun Park Y
J Hepatol; 2003 Nov; 39(5):786-92. PubMed ID: 14568262
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma.
Zhang SH; Xu AM; Chen XF; Li DH; Sun MP; Wang YJ
Hum Pathol; 2008 Dec; 39(12):1827-34. PubMed ID: 18715617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]